Stockreport

Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency

Cellyan Biotechnology Co., Ltd - Class A Ordinary Shares  (HKPD) 
PDF HONG KONG, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Cellyan Biotechnology Co., Ltd (Nasdaq: HKPD) (the "Company"), a leading provider of over the counter (“OTC”) pharmaceutic [Read more]